Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.

BibTeX

@article{allodium:10.1002/ejhf.1920,
  title = {Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.},
  author = {Lyon AR and Dent S and Stanway S and Earl H and Brezden-Masley C and Cohen-Solal A and Tocchetti CG and Moslehi JJ and Groarke JD and Bergler-Klein J and Khoo V and Tan LL and Anker MS and von Haehling S and Maack C and Pudil R and Barac A and Thavendiranathan P and Ky B and Neilan TG and Belenkov Y and Rosen SD and Iakobishvili Z and Sverdlov AL and Hajjar LA and Macedo AVS and Manisty C and Ciardiello F and Farmakis D and de Boer RA and Skouri H and Suter TM and Cardinale D and Witteles RM and Fradley MG and Herrmann J and Cornell RF and Wechelaker A and Mauro MJ and Milojkovic D and de Lavallade H and Ruschitzka F and Coats AJS and Seferovic PM and Chioncel O and Thum T and Bauersachs J and Andres MS and Wright DJ and López-Fernández T and Plummer C and Lenihan D},
  year = {2020},
  journal = {European journal of heart failure},
  doi = {10.1002/ejhf.1920},
  url = {https://doi.org/10.1002/ejhf.1920}
}

RIS

TY  - JOUR
TI  - Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
AU  - Lyon AR
AU  - Dent S
AU  - Stanway S
AU  - Earl H
AU  - Brezden-Masley C
AU  - Cohen-Solal A
AU  - Tocchetti CG
AU  - Moslehi JJ
AU  - Groarke JD
AU  - Bergler-Klein J
AU  - Khoo V
AU  - Tan LL
AU  - Anker MS
AU  - von Haehling S
AU  - Maack C
AU  - Pudil R
AU  - Barac A
AU  - Thavendiranathan P
AU  - Ky B
AU  - Neilan TG
AU  - Belenkov Y
AU  - Rosen SD
AU  - Iakobishvili Z
AU  - Sverdlov AL
AU  - Hajjar LA
AU  - Macedo AVS
AU  - Manisty C
AU  - Ciardiello F
AU  - Farmakis D
AU  - de Boer RA
AU  - Skouri H
AU  - Suter TM
AU  - Cardinale D
AU  - Witteles RM
AU  - Fradley MG
AU  - Herrmann J
AU  - Cornell RF
AU  - Wechelaker A
AU  - Mauro MJ
AU  - Milojkovic D
AU  - de Lavallade H
AU  - Ruschitzka F
AU  - Coats AJS
AU  - Seferovic PM
AU  - Chioncel O
AU  - Thum T
AU  - Bauersachs J
AU  - Andres MS
AU  - Wright DJ
AU  - López-Fernández T
AU  - Plummer C
AU  - Lenihan D
PY  - 2020
JO  - European journal of heart failure
DO  - 10.1002/ejhf.1920
UR  - https://doi.org/10.1002/ejhf.1920
ER  - 

APA

AR, L., S, D., S, S., H, E., C, B., A, C., CG, T., JJ, M., JD, G., J, B., V, K., LL, T., MS, A., S, V. H., C, M., R, P., A, B., P, T., B, K., TG, N., Y, B., SD, R., Z, I., AL, S., LA, H., AVS, M., C, M., F, C., D, F., RA, D. B., H, S., TM, S., D, C., RM, W., MG, F., J, H., RF, C., A, W., MJ, M., D, M., H, D. L., F, R., AJS, C., PM, S., O, C., T, T., J, B., MS, A., DJ, W., T, L., C, P., & D, L. (2020). Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.. European journal of heart failure. https://doi.org/10.1002/ejhf.1920